One patient from the diabetes group had a transient increase in albumin-corrected calcium to 2.91 mmol/L on Day 1 after taking the drug; in all the other patients, the calcium levels did not exceed the reference range at any point of the study. The gene discussed is ALB; the disease is diabetes mellitus.